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Chronic inflammationof the largerairways is a commonoccurrence inchildren.Anumberof factors
suchasyounger age,prematurebirth,malegender, exposure toenvironmental smokeorpollution,
and crowded housing can increase a child’s susceptibility to chronic lung disease. Chronic bron-
chitismaybe caused by an underlying humoral immunodeficiency if the clinical course is recurrent
or prolonged. Primary humoral immunodeficiency accounts for approximately 70% of all immuno-
deficiencies. The differential of chronic bronchitis also includes Cystic Fibrosis, ciliary defects and
immune cellular and phagocytic defects.1,2 This reviewwill summarize themost common humoral
antibody based immune based deficiencies associated with chronic pulmonary disease.
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512 A. DosanjhIntroduction significantly diminished. Delayed-type hypersensitivity andPrimary Immune Deficiency is an identified cause of chronic
bronchitis and recurrent pneumonia. The early identifica-
tion and management of primary humoral immunodefi-
ciency may help preserve lung function and lung growth.
Failure to thrive and secondary heart disease may occur
once bronchitis is established. Most patients with humoral
immunodeficiency do not have fungal, mycobacterial or
non-enteroviral disease.
The presentation of humoral deficiency tends to occur in
the first years of life rather than at birth, since there is
a passive transfer of maternal IgG, and a delay in fetal
production of antibodies.3 Preventive strategies include the
use of secretion mobilization, vaccination and possibly
prophylactic inhaled or oral antibiotics. The mainstay of
therapy for most of the diseases described in this review is
intravenous immunoglobulin (IVIG). The goal of this review
is to describe the pathophysiology, clinical diagnosis and
management of chronic lung diseases caused by primary
humoral immunodeficiency.
X-Linked agammaglobulinemia
X-Linked agammaglobulinemia (XLA) is one of the primary
immunodeficiencies, and is inherited by presence of
a mutation located on the X chromosome, encoding for
tyrosine kinase, a key regulator of B cell maturation. There
have been hundreds of mutations in the Bruton’s tyrosine
kinase gene identified.3As a result in XLA, otherwise known
as Bruton’s disease, B cell numbers are low and B cell
function is affected. T cell function and numbers are
preserved and cell-mediated responses are normal. The
clinical presentation commonly includes an uneventful
course for the first six to nine months of life. Once maternal
protective antibody levels diminish, recurrent sino-pulmo-
nary bacterial infections begin to develop in the first year.
A family history of first degree relatives with a similar
history can help elucidate the diagnosis.4
Children with XLA can be diagnosed later in the course,
since each individual infection may be treated with anti-
biotics and the pattern of recurrent infections may be
overlooked. Late diagnosis carries with it the enhanced risk
of bronchiectasis and the diagnosis is often delayed by 2e5
years from time of presentation. Chest radiographs and
careful history will often reveal a chronic course of
persistent or recurrent lung disease. Radiographic findings
typically associated are bronchiectasis, atelectasis and
bronchial wall thickening. In one study of 19 pediatric
patients with primary immunodeficiency, high resolution
computerized tomograms (HRCT) were scored for presence
of mucus plugs, bronchiectasis, air trapping, alveolitis,
airway thickening and consolidation. The results described
a scoring system which may be used to follow and monitor
patients.5
Diagnostic features include low or absent levels of all
the major immunoglobulins such as IgG, IgA and IgM since B
cell differentiation occurs in patients with Bruton’s agam-
maglobulinemia. There is sometimes associated neu-
tropenia. CD3, CD4, and CD8 lymphocyte populations are
preserved, but CD19/20 lymphocyte subsets arein vitro T cell proliferation are normal, while specific
antibody responses are weak.6,7
Typical respiratory pathogens include Hemophilus
Influenzae, Pseudomonas aeruginosa, Streptococcus pneu-
moniae, ECHO virus, and Mycoplasma pneumoniae.1
Patients will typically respond to appropriate antibiotics
and intravenous immunoglobulin (IVIG) replacement
therapy. Some patients who have underlying lung damage
at the time of treatment will present with bronchiectasis.2
Selective IgA deficiency
As the most common primary humoral immunodeficiency,
as many as 1 in 333 caucasians may be affected with IgA
deficiency. Asians and African Americans are generally less
commonly afflicted. Both environmental and genetic risk
factors contribute to the condition, and it is often present
in healthy individuals. Some patients present with
increased susceptibility to gastrointestinal and respiratory
infections, while others have an increased risk for allergic
or autoimmune diseases.
Clinical presentation with recurrent or problematic viral
or bacterial pulmonary infections is common and similar to
those associated with XLA. The infections can be controlled
with appropriate use of antibiotics. Since patients have
a normal IgG and possibly anti-IgA antibodies, there is no role
for the use of intravenous replacement. IgA deficiency unlike
XLA is a selective defect in the defense of mucosal surfaces,
and replacement strategies are therefore not as effective.
Diagnostic laboratory results include a significantly
diminished IgA, with a normal IgG, T cell function and
number. Since children do not reach adult levels of IgA until
around eight years of age, the diagnosis is often delayed
until the child is at least four years old.1,6 IgA deficiency is
also found in association with IgG2 deficiency and CVID.
There is also a defect in T cell priming by antigens in most
patients. As a result there is a dysfunction in Ag-presenting
cells and increased production of IFN-gamma by CD8þ
cells, enhanced rates of apoptosis, and often a presence of
auto anti-IgA antibodies.8
IgG subclass deficiency
Most patients with IgG subclass deficiency are without
symptoms, but some patients do have recurrent sino-
pulmonary infections. IgG2 deficiency in particular results
in lack of production of antibodies against polysaccharides
and recurrent infection with encapsulated bacteria. Diag-
nostic workup should include specific antibody levels to
a broad array of protein and polysaccharide antigens to
provide a mechanistic correlate to the IgG subclass defi-
ciency. As noted above some patients also may have IgA
deficiency. There are no described T or B cell proliferation
defects, and IVIG may be useful in some patients.9
Combined variable immunodeficiency (CVID)
Combined Variable Immunodeficiency (CVID) is a heteroge-
neous group of disorders characterized by hypo-
gammaglobulinemia and defective specific antibody
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ders, with an estimated incidence of 1: 10,000. Thus, it is
far rarer than IgA deficiency. It tends to present later in
childhood with recurrent sino-pulmonary infections caused
by similar pathogens as found with XLA or IgA deficiency.
CVID patients have normal blood T and surface Ig-bearing B
cells and are able to defend normally against fungal and
viral infections. Approximately 10% of CVID patients have
recurrent wheezing.9 In contrast to XLA, the pattern of
inheritance is thought to be autosomal dominant and it
presents later in life. As a result of low levels of all major
immunoglobulins, XLA and CVID share many more clinical
features in comparison to IgA deficiency. The presentation
in CVID unlike XLA, rarely involves enteroviral meningoen-
cephalitis. On physical exam, patients with CVID have
normal tonsillar tissue, and approximately 15e25% exhibit
lymphadenopathy or splenomegaly.3,6
CVID is associated with enhanced risk for cancer, lym-
phoproliferative and autoimmune diseases. Diagnostic
evaluation is characterized by, normal CD3, 4, 8 lympho-
cyte levels, anemia, decreased immunoglobulin levels, with
weak specific antibody levels. Treatment is similar to Bru-
ton’s agammaglobulinemia which uses intravenous immu-
noglobulin and antibiotics to prevent ongoing lung damage
and subsequent infections.Hyperimmunoglobulin E or job syndrome
Since Buckley et al. reported the details of the clinical
presentation of patients with hyperimmunoglobulin E (IgE) in
patients with hyperimmunoglobulin E syndrome, recurrent
cystic lung disease has been recognized as one of the later
features of the disease. Underlying molecular causes of this
rare disease (1:1,000,000) include mutations of signal trans-
duction and activation of transcription 3 (STAT3) gene.9,10
The pulmonary manifestations begin with recurrent viral
infections and Staphylococcus aureus infections with subse-
quent chronic cystic lung disease. The pulmonary problems
typically present after recurrence of staphylococcal skin
abscesses. Patients who inherit the disorder in an autosomal
recessive manner tend to lack pneumatocele formation. The
patients with autosomal dominant disease have severe
pulmonary disease and pneumatocele formation which can
lead to early mortality. Pneumatoceles are associated with
recurrent pneumonia in 80%of patients. Despite thepresence
of high levels of IgE, patients with Jobs syndrome do not
typically have wheezing or bronchial hyperresponsiveness. In
contrast, children present with chronic cough productive of
prurulent sputum, rhonchi and rales on physical examination.
Diagnostic evaluation should include CT scans of the lung to
detect pneumatoceles, pulmonary function testing and
possibly broncho-alveolar lavage to identify typical organ-
isms. Specific pathogens which are common include
S. aureus, S. pneumoniae and H. influenzae. Secondary
organisms infecting pneumatoceles are Pseudomonas,
Aspergillus and non tuberculosis species. Investigational
studies on peripheral blood mononuclear cells may show low
IFN-gamma responses to S. aureus. Immunoglobulin E (IgE)
levels above two standard deviations are also characteristic
of the diagnosis. Among infants, the IgE level may be lower
than anticipated in suspected cases of Jobs syndrome.10e12The treatment strategies for the management of pulmonary
infections in Job’s syndrome include IVIG, vaccines and
regular visits to the specialist to evaluate lung function.
Hyper-IgM deficiency
Patients with autosomal recessive and X-linked forms of
Hyper-IgM have elevated total IgM and very low levels of
IgG, IgA and IgE, but retain normal T cells function. The
disease is rare with an estimated incidence as low as 1/1
million live births.13 The autosomal forms are caused by
defective enzymes (activation-induced cytidine deaminase
or Uracil nucleoside glycosylase) needed for B cell devel-
opment and antibody production. In the autosomal form,
cellular immunity is typically not affected.3 The clinical
pulmonary presentation reflects the loss of resistance to
encapsulated bacteria and patients have recurrent sino-
pulmonary infections. On physical exam, there is lymphoid
hyperplasia in the autosomal forms of the disease. The
treatment includes prevention of infection and IVIG
administration.8 In a study of 79 patients from 60 unrelated
families with X-linked hyper-IgM syndrome, over 90% had
developed symptoms by age 4 years. The same study
reported that the most prominent infection was pneumonia
(81%). The underlying infectious cause of the pneumoniae
included encapsulated bacteria, CMV, histoplasmosis and
P. jiroveci.13 Compared to isolated defects of humoral
immunity, and those with the autosomal form of Hyper-IgM
syndrome, patients with the X-linked form are at risk for
fungal pneumonias, such as those caused by Candida,
Cryptococcus and Histoplasma.14
Specific diagnostic evaluations
Chronic bronchitis is associated with slowly resolving or
persistent symptoms such as productive cough, sputum
production and intermittent fevers. Chest radiographic
findings are atelectasis, bronchiectasis or focal consolida-
tion. A sputum analysis for bacterial as well as viral agents
such as adenovirus is helpful in guiding antibiotic therapy
and providing a pattern of infection with certain pathogens.
An appropriate first step in diagnosis is a complete blood
count with differential (CBC). This will establish whether lym-
phopenia or anemia is present.12,15 Normal lymphocyte counts
in infants are typically higher than in adults. The CBC remains
abasicand inexpensive screeningtest ifagedbasednormalsare
used in its interpretation. If there is a lymphocyte count of less
than 3000 lymphocytes/cubic mm or age specific normal
values, then a flow cytometry is indicated to identify specific
lymphocyte subsets which may be abnormal. The use of flow
cytometry is also indicated if there is clinical suspicion. Among
very young patients, flow cytometrymay bemore useful, since
maternally derived lymphocytes may still be present and an
absolute count alone would not distinguish the source. For
functional analysis, cutaneous delayed-type hypersensitivity
testing (DTH) is used to document a positive response. A posi-
tiveDTHsuggests thatuptake,processingbyantigenpresenting
cells to helper T cells and subsequent activation of monocytes
andmacrophages is intact. The drawbacks of this test are that:
it requires intracutaneous antigen injection; is often sup-
pressed during an infection or use of immunoregulatory drugs;
Table 1 A summary of the pulmonary findings and key laboratory findings associated with each disease.
XLA Bronchiectasis recurrent H. influenzae and S. pneumoniae Low or absent immunoglobulins
IgA Recurrent bacterial infections; Associated sinus infections Low IgA
CVID Recurrent bacterial infections; Increased risk for malignancy Decreased immunoglobulins and decreased
specific antibody responses
Job syndrome Pneumatoceles, abscesses, pneumoniae, Staph. aureus,
Pseudomonas, Aspergillus, Pneumocystis jiroveci
IgE greater than two std deviations from
the mean for age
514 A. Dosanjhand is unreliable in children under the age of one year. The
response necessitates that the patient return to have the skin
test read at 48 or 72 h after injection. Induration of more than
5 mm is considered positive.15
Other essential screening tests are total serum immu-
noglobulins, IgG, IgA and IgM along with subclass levels of
IgG. If X-linked disease is suspected, carrier detection is
performed, in which 50% of mothers are expected to be
carriers.15e17 Table 1 summarizes the pulmonary manifes-
tations of each of the diseases discussed, along with the key
immunologic diagnostic findings.
Conclusions
Primary immunodeficiency is a common cause of recurrent
bronchitis or bronchiectasis.
The identification of primary humoral immunodefi-
ciencies begins with clinical suspicion and relies on accu-
rate history, family history and physical exam and pathogen
analysis. The preliminary screening tests may be performed
in the office or clinic setting, before referral to an immu-
nologist for further evaluation.
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